By Sam Robinson
Publication Date: 2026-10-26 11:55:00
In addition, Boehringer and Microsoft are partnering on security and data centre modernisation, alongside projects involving Boehringer’s Animal Health division, company-wide business processes and technology infrastructure.
“Successful AI adoption depends on more than technology alone,” says Harsha Deshmukh, who is a Member of the Board of Managing Directors at Boehringer Ingelheim and responsible for IT and Global Business Services.
“What matters is enabling our employees to use AI responsibly and unlock its potential through scalable solutions across the complete value chain and all business units.”
Boehringer Ingelheim – key partners
Eli Lilly
CEO: David A. Ricks | HQ: Indianapolis, Indiana
Eli Lilly and Boehringer Ingelheim have a long-standing pharmaceutical alliance focused on developing and commercialising medicines for type 2 diabetes and related conditions. Their collaboration combines expertise in drug discovery, clinical development and…
